Mitsubishi UFJ Asset Management Co. Ltd. grew its stake in Lam Research Corporation (NASDAQ:LRCX - Free Report) by 1.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,994,239 shares of the semiconductor company's stock after buying an additional 32,991 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.24% of Lam Research worth $554,114,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of the stock. Generali Investments Management Co LLC increased its position in shares of Lam Research by 62.0% during the fourth quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company's stock worth $6,209,000 after purchasing an additional 13,878 shares in the last quarter. Lingohr Asset Management GmbH boosted its position in shares of Lam Research by 590.7% in the 3rd quarter. Lingohr Asset Management GmbH now owns 59,555 shares of the semiconductor company's stock valued at $7,974,000 after purchasing an additional 50,933 shares during the period. Mediolanum International Funds Ltd increased its position in Lam Research by 52.0% during the third quarter. Mediolanum International Funds Ltd now owns 262,544 shares of the semiconductor company's stock worth $34,417,000 after buying an additional 89,856 shares during the period. First Citizens Bank & Trust Co. lifted its stake in Lam Research by 8.0% in the third quarter. First Citizens Bank & Trust Co. now owns 140,433 shares of the semiconductor company's stock valued at $18,804,000 after buying an additional 10,408 shares during the last quarter. Finally, Thoroughbred Financial Services LLC increased its stake in Lam Research by 115.2% in the third quarter. Thoroughbred Financial Services LLC now owns 22,198 shares of the semiconductor company's stock valued at $2,972,000 after purchasing an additional 11,883 shares during the period. 84.61% of the stock is owned by hedge funds and other institutional investors.
Lam Research Stock Performance
Lam Research stock opened at $275.80 on Wednesday. The company has a market cap of $344.91 billion, a price-to-earnings ratio of 52.04, a price-to-earnings-growth ratio of 2.14 and a beta of 1.81. The company has a debt-to-equity ratio of 0.35, a current ratio of 2.54 and a quick ratio of 1.77. Lam Research Corporation has a 12 month low of $72.59 and a 12 month high of $280.00. The stock's 50-day moving average is $236.99 and its 200-day moving average is $202.86.
Lam Research (NASDAQ:LRCX - Get Free Report) last announced its earnings results on Wednesday, April 22nd. The semiconductor company reported $1.47 EPS for the quarter, beating the consensus estimate of $1.36 by $0.11. The business had revenue of $5.84 billion for the quarter, compared to the consensus estimate of $5.70 billion. Lam Research had a return on equity of 66.21% and a net margin of 30.94%.The company's revenue was up 23.8% on a year-over-year basis. During the same period last year, the business posted $1.04 EPS. Lam Research has set its Q4 2026 guidance at 1.500-1.800 EPS. Equities analysts anticipate that Lam Research Corporation will post 5.68 earnings per share for the current year.
Insider Activity
In other news, Director Eric Brandt sold 35,000 shares of the business's stock in a transaction on Friday, February 6th. The shares were sold at an average price of $225.60, for a total transaction of $7,896,000.00. Following the transaction, the director directly owned 253,705 shares of the company's stock, valued at approximately $57,235,848. The trade was a 12.12% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Douglas R. Bettinger sold 50,057 shares of the company's stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total transaction of $11,214,269.71. Following the completion of the transaction, the chief financial officer owned 1,081,705 shares of the company's stock, valued at $242,334,371.15. This trade represents a 4.42% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 155,066 shares of company stock worth $35,849,242. Company insiders own 0.31% of the company's stock.
Key Headlines Impacting Lam Research
Here are the key news stories impacting Lam Research this week:
- Positive Sentiment: Earnings beat + bullish near‑term guide — Lam reported a March‑quarter revenue and EPS beat and gave an upbeat June‑quarter outlook, which the market interpreted as accelerating wafer‑fab demand and margin expansion. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
- Positive Sentiment: TAM and secular demand lift the investment case — Analysts and commentators raised WFE and hyperscaler‑capex forecasts (Lam’s environment looks larger), reinforcing growth expectations and the claim that AI-driven device complexity benefits Lam’s etch/deposition exposure. Lam Research: $140B WFE, $725B In Hyperscaler Capex, And Still Raising -- BUY
- Positive Sentiment: Analyst target upgrades and bullish notes — Multiple firms have raised price targets and reiterated Outperform/Buy calls after the quarter, supporting momentum and upside thesis. Lam Research (LRCX) Surges to Record Highs: Analyzing the 252% Rally
- Positive Sentiment: Technical breakout / IBD recognition — The stock cleared an IBD buy point after the strong report, drawing momentum and retail/institutional interest. Lam Research, IBD Stock Of The Day, Clears Buy Point On Chip-Gear Investments
- Neutral Sentiment: Insider sale disclosed — An SVP sold ~18k shares under a pre‑arranged Rule 10b5‑1 plan; routine disclosure but worth noting for timing/context. Insider Selling: Lam Research NASDAQ: LRCX SVP Sells 18,170 Shares of Stock
- Neutral Sentiment: Valuation and “froth” commentary — Some analysis flags stretched multiples and consolidation risk after the run; elevated P/E requires investors to weigh growth vs. premium valuation. Lam Research Is Approaching Frothy Levels
- Negative Sentiment: Insider and institutional selling activity — Reports show multiple executive sales and notable institutional repositioning in recent quarters; while some are pre‑planned or rebalancing, sustained selling can temper sentiment if it continues. Lam Research jumps 7% as earnings beat and June-quarter outlook signals accelerating wafer-fab demand
Analyst Ratings Changes
A number of research firms have issued reports on LRCX. Royal Bank Of Canada upped their target price on shares of Lam Research from $290.00 to $310.00 and gave the company an "outperform" rating in a report on Thursday, April 23rd. B. Riley Financial reaffirmed a "buy" rating on shares of Lam Research in a research report on Monday, April 20th. Wall Street Zen raised Lam Research from a "hold" rating to a "buy" rating in a research note on Saturday. New Street Research increased their price objective on shares of Lam Research from $235.00 to $280.00 and gave the stock a "neutral" rating in a report on Monday, April 27th. Finally, Evercore raised their target price on shares of Lam Research from $275.00 to $300.00 and gave the stock an "outperform" rating in a research report on Thursday, April 23rd. Twenty-six analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $285.94.
Check Out Our Latest Analysis on LRCX
Lam Research Profile
(
Free Report)
Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.
Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lam Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lam Research wasn't on the list.
While Lam Research currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.